Serum Osteocalcin as a Marker for Vitamin K-Status in Pregnant Women and Their Newborn Babies

Summary

Osteocalcin (bone Gla-protein) is a vitamin K-dependent protein synthesized by osteoblasts. Its hydroxylapatite binding capacity (HBC) is generally used to estimate the Gla-content of circulating osteocalcin. Here we have used the HBC of serum osteocalcin as a marker for the vitamin K-status in pregnant women and their offspring. For all cases investigated the HBC values in the cord samples were substantially lower than in the corresponding maternal ones. Babies from mothers who had been treated with vitamin K during the last 6 weeks prior to delivery, had significantly higher HBC values than those from a placebo group. The results presented in this paper are indicative for a generally occurring vitamin K deficiency in newborns. At delivery the HBC in untreated women was low as well. In both the placebo- and the vitamin K-group a good correlation was found between the HBC values in paired samples from mother and child. Whether the maternal HBC value may be used as a prenatal marker for estimating the fetal vitamin K-status remains to be seen.

• REFERENCES

• 1 Vermeer C. Gammacarboxyglutamate-containing proteins and the vitamin K-dependent carboxylase. Biochem J 1990; 266: 625-636
• 2 Friedman PA. Vitamin K-dependent proteins. N Engl J Med 1984; 310: 1458-1460
• 3 Vermeer C, hamulyák K. Pathophysiology of vitamin K-deficiency and oral anticoagulants. Thromb Haemostas 1991; 66: 1253-1259
• 4 Bleyer WA, Skinner AL. Fatal neonatal haemorrhage after maternal anticonvulsant therapy. JAMA 1976; 235: 626-627
• 5 Stevenson RE, Burton M, Fenlanto GJ. Hazards of oral anticoagulants during pregnancy. JAMA 1980; 243: 1549-1551
• 6 O’Connor ME, Livingstone DS, Hannah J, Wilkins D. Vitamin K deficiency and breast-feeding. Am J Dis Child 1983; 137: 601-602
• 7 Haroon Y, Shearer MJ, Rahim S, Gunn WC, McEnery G, Barkhan P. The content of phylloquinone (vitamin K₁) in human milk, cow’s milk and infant formula foods determined by high-performance liquid chromatography. J Nutr 1982; 112: 1105-1117
• 8 Nagao T, Nakayama K. Vitamin K deficiency in Japan. Pediatrics 1984; 74: 315-316
• 9 von Kries R, Shearer MJ, Göbel U. Vitamin K in infancy. Eur J Pediatr 1988; 147: 106-112
• 10 Shearer MJ. Vitamin K and vitamin K-dependent proteins. Br J Haematol 1990; 75: 156-162
• 11 Shearer MJ, Rahim S, Barkhan P, Stimmler L. Plasma vitamin K₁ in mothers and their newborn babies. Lancet 1982; ii: 460-463
• 12 Kindberg CG, Suttie JW. Effect of various intakes of phylloquinone on signs of vitamin K deficiency and serum and liver phylloquinone concentrations in the rat. J Nutr 1989; 119: 175-180
• 13 Usui Y, Tanimura H, Nishimura N, Kobayashi N, Okanoue T, Ozawa K. Vitamin K concentrations in the plasma and liver of surgical patients. Am J Clin Nutr 1990; 51: 846-852
• 14 Yao S-N, DeSilva AH, Kurachi S, Samuelson LC, Kurachi K. Characterization of a mouse factor IX cDNA and developmental regulation of the factor IX gene experession in liver. Thromb Haemostas 1991; 65: 52-58
• 15 Jamison CS, Degen SJF. Prenatal and postnatal expression of mRNA coding for rat prothrombin. Biochim Biophys Acta 1991; 1088: 208-216
• 16 Motohara K, Endo F, Matsuda I. Effect of vitamin K administration on acarboxy prothrombin (PIVKA-II) levels in newborns. Lancet 1985; ii: 242-244
• 17 Blanchard RA, Furie BC, Barnett J, Peck C, Faye K, Jacobs M, DeFurio L, Furie B. Vitamin K deficiency in newborns and their mothers. Thromb Haemostas 1985; 54: 1340
• 18 Knapen MHJ, Hamulyák K, Vermeer C. The effect of vitamin K supplementation on circulating osteocalcin (bone Gla-protein) and urinary calcium excretion. Ann Intern Med 1989; 111: 1001-1005
• 19 Price PA. Role of vitamin K-dependent proteins in bone metabolism. Annu Rev Nutr 1988; 8: 565-583
• 20 Levine MN, Hirsh J. Sample size in the planning and interpretation of clinical trials. Thromb Haemostas 1987; 58: 953-956
• 21 Vermeer C, Soute BAM, Hemker HC. A new method for the preparation of artificial factor II reagents from normal human and bovine plasma. Thromb Res 1977; 10: 495-507
• 22 Suttie JW, Kindberg CG, Greger JL, Bang NU. Effects of vitamin K (phylloquinone) restriction in the human. In: Current Advances in Vitamin K Research.. Suttie JW. (ed) Elsevier, New York: 1988. pp 465-476
• 23 Hart JP, Shearer MJ, McCarthy PT. Enhanced sensitivity for the determination of endogenous phylloquinone (vitamin K₁) in plasma using high-performance liquid chromatography with dual electrode electrochemical detection. Analyst. 1985; 110: 1181-1184
• 24 Cole DEC, Carpenter TO, Gundberg CM. Serum osteocalcin concentrations in children with metabolic bone disease. J Pediatr 1985; 106: 770-776
• 25 Pietersma-de Bruyn ALJM. Vitamin K in the newborn. Thesis, Leiden 1990
• 26 Soulier JP, Gozin D, Lefrere JJ. A new method to assay desgamma-carboxyprothrombin. Results obtained in 75 cases of hepatocellular carcinoma. Gastroenterology 1986; 91: 1258-1262
• 27 van Haarlem LJM, Knapen MHJ, Hamulyák K, Vermeer C. Circulating osteocalcin during oral anticoagulant therapy. Thromb Haemostas 1988; 60: 79-82
• 28 Hamulyák K, de Boer-van den Berg MAG, Thijssen HHW, Hemker HC, Vermeer C. The placental transport of [³H]vitamin K₁ in rats. Br J Haematol. 1987; 65: 335-338
• 29 Mandelbrot L, Guillaumont M, Leclercq M, Lefrere JJ, Gozin D, Daffos F, Forestier F. Placental transfer of vitamin K₁ and its implications in fetal hemostasis. Thromb Haemostas. 1988; 60: 39-43
• 30 Deblay MF, Vert P, Andre M, Marchal F. Transplacental vitamin K prevents haemorrhagic disease of infant of epileptic mother. Lancet 1982; i: 1247
• 31 Lane PA, Hathaway WE. Vitamin K in infancy. J Pediatr 1985; 3: 351-359